INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Corporate insider
KA

Khan Bilal Arshad

DirectorCIK 0002108044

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells2 / 0
Max Insider Score50
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
47
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$320K
20.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SpyGlass Pharma, Inc.Director · Feb 9, 2026
50
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY
$1.84M
115.0K sh
Feb 9, 2026
Feb 11, 2026
traded Feb 9, 2026
+2d
SEC FORM 4

Evidence

9
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Grant or award
A—
13.7K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence